AAAAAA
Results: 1-25/32
Authors:
Berends, MJW
Wu, Y
Sijmons, RH
Mensink, RGJ
van der Sluis, T
Hordijk-Hos, JM
de Vries, EGE
Hollema, H
Karrenbeld, A
Buys, CHCM
van der Zee, AGJ
Hofstra, RMW
Kleibeuker, JH
Citation: Mjw. Berends et al., Molecular and clinical characteristics of MSH6 variants: An analysis of 25index carriers of a germline variant, AM J HU GEN, 70(1), 2002, pp. 26-37
Authors:
de Hullu, JA
Piers, DA
Hollema, H
Aalders, JG
van der Zee, AGJ
Citation: Ja. De Hullu et al., Sentinel lymph node detection in locally recurrent carcinoma of the vulva, BR J OBST G, 108(7), 2001, pp. 766-768
Authors:
Wu, Y
Berends, MJW
Sijmons, RH
Mensink, RGJ
Verlind, E
Kooi, KA
van der Sluis, T
Kempinga, C
van der Zee, AGJ
Hollema, H
Buys, CHCM
Kleibeuker, JH
Hofstra, RMW
Citation: Y. Wu et al., A role for MLH3 in hereditary nonpolyposis colorectal cancer, NAT GENET, 29(2), 2001, pp. 137-138
Authors:
Glas, AS
Vermey, A
Hollema, H
Robinson, PH
Roodenburg, JLN
Nap, RE
Plukker, JTM
Citation: As. Glas et al., Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients, HEAD NECK, 23(4), 2001, pp. 311-316
Authors:
Esajas, MD
Duk, JM
de Bruijn, HWA
Aalders, JG
Willemse, PHB
Sluiter, W
Pras, B
ten Hoor, K
Hollema, H
van der Zee, AGJ
Citation: Md. Esajas et al., Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer, J CL ONCOL, 19(19), 2001, pp. 3960-3966
Authors:
van Leeuwen, FE
Bergman, L
Beelen, MLR
Gallee, MPW
Hollema, H
Citation: Fe. Van Leeuwen et al., Tamoxifen and risk of endometrial cancer - Reply, LANCET, 357(9249), 2001, pp. 67-67
Authors:
Mourits, MJE
De Vries, EGE
Willemse, PHB
Ten Hoor, KA
Hollema, H
Van der Zee, AGJ
Citation: Mje. Mourits et al., Tamoxifen treatment and gynecologic side effects: A review, OBSTET GYN, 97(5), 2001, pp. 855-866
Authors:
Berends, MJW
Hollema, H
Wu, Y
van der Sluis, T
Mensink, RGJ
ten Hoor, KA
Sijmons, RH
de Vries, EGE
Pras, E
Mourits, MJE
Hofstra, RMW
Buys, CHCM
Kleibeuker, JH
van der Zee, AGJ
Citation: Mjw. Berends et al., MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer, INT J CANC, 92(3), 2001, pp. 398-403
Authors:
Wisman, GBA
Knol, AJ
Helder, MN
Krans, M
de Vries, EGE
Hollema, H
de Jong, S
van der Zee, AGJ
Citation: Gba. Wisman et al., Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer, INT J CANC, 91(5), 2001, pp. 658-664
Authors:
Wu, Y
Berends, MJW
Post, JG
Mensink, RGJ
Verlind, E
Van Der Sluis, T
Kempinga, C
Sijmons, RH
Van der Zee, AGJ
Hollema, H
Kleibeuker, JH
Buys, CHCM
Hofstra, RMW
Citation: Y. Wu et al., Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms, GASTROENTY, 120(7), 2001, pp. 1580-1587
Authors:
Klimp, AH
Hollema, H
Kempinga, C
van der Zee, AGJ
de Vries, EGE
Daemen, T
Citation: Ah. Klimp et al., Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages, CANCER RES, 61(19), 2001, pp. 7305-7309
Authors:
McLaughlin, PMJ
Harmsen, MC
Dokter, WHA
Kroesen, BJ
van der Molen, H
Brinker, MGL
Hollema, H
Ruiters, MHJ
Buys, CHCM
de Leij, LFMH
Citation: Pmj. Mclaughlin et al., The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: A new model to study carcinoma-directed immunotherapy, CANCER RES, 61(10), 2001, pp. 4105-4111
Authors:
Komdeur, R
Plaat, BEC
Hoekstra, HJ
Molenaar, WM
Hollema, H
van den Berg, E
Mastik, MF
van der Graaf, WTA
Citation: R. Komdeur et al., Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before andafter hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan, CANCER, 91(10), 2001, pp. 1940-1948
Authors:
Sijmons, R
Hofstra, R
Hollema, H
Mensink, R
van der Hout, A
Hoekstra, H
Kleibeuker, J
Molenaar, W
Wijnen, J
Fodde, R
Vasen, H
Buys, C
Citation: R. Sijmons et al., Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer, GENE CHROM, 29(4), 2000, pp. 353-355
Authors:
Plaat, BEC
Hollema, H
Molenaar, WM
Broers, GHT
Piipe, J
Mastik, MF
Hoekstra, HJ
van den Berg, E
Scheper, RJ
van der Graaf, WTA
Citation: Bec. Plaat et al., Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors:Differences in clinical outcome and expression of multidrug resistance proteins, J CL ONCOL, 18(18), 2000, pp. 3211-3220
Authors:
de Hullu, JA
Hollema, H
Piers, DA
Verheijen, RHM
van Diest, PJ
Mourits, MJE
Aalders, JG
van der Zee, AGJ
Citation: Ja. De Hullu et al., Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva, J CL ONCOL, 18(15), 2000, pp. 2811-2816
Authors:
Bergman, L
Beelen, MLR
Gallee, MPW
Hollema, H
Benraadt, J
van Leeuwen, FE
Citation: L. Bergman et al., Risk and prognosis of endometrial cancer after tamoxifen for breast cancer, LANCET, 356(9233), 2000, pp. 881-887
Authors:
Engelen, MJA
de Bruijn, HWA
Hollema, H
ten Koor, KA
Willemse, PHB
Aalders, JG
van der Zee, AGJ
Citation: Mja. Engelen et al., Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors, GYNECOL ONC, 78(1), 2000, pp. 16-20
Authors:
Berends, MJW
Cats, A
Hollema, H
Karrenbeld, A
Beentjes, JAM
Sijmons, RH
Mensink, RGJ
Hofstra, RMW
Verschueren, RCJ
Kleibeuker, JH
Citation: Mjw. Berends et al., Adrenocortical adenocarcinoma in an MSH2 carrier: Coincidence or causal relation?, HUMAN PATH, 31(12), 2000, pp. 1522-1527
Authors:
Wisman, GBA
De Jong, S
Meersma, GJ
Helder, MN
Hollema, H
de Vries, EGE
Keith, WN
van der Zee, AGJ
Citation: Gba. Wisman et al., Telomerase in (pre)neoplastic cervical disease, HUMAN PATH, 31(10), 2000, pp. 1304-1312
Authors:
Plaat, BEC
Molenaar, WM
Sagrudny, J
Bohle, RM
Mastik, MF
Hoekstra, HJ
Van der Graaf, WTA
Hollema, H
van den Berg, E
Citation: Bec. Plaat et al., The 16p11 breakpoint in myxoid liposarcomas might affect the expression ofthe LRP gene on 16p11.2 encoding the multidrug resistance associated majorvault protein, EUR J CL IN, 30(5), 2000, pp. 447-453
Authors:
De Hullu, JA
Pruim, J
Que, TH
Aalders, JG
Boonstra, H
Vaalburg, W
Hollema, H
van der Zee, AGJ
Citation: Ja. De Hullu et al., Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L-[1-C-11]-tyrosine positron emission tomography, INT J GYN C, 9(2), 1999, pp. 141-146
Authors:
Berends, MJW
Kleibeuker, JH
de Vries, EGE
Mourits, MJE
Hollema, H
Pras, E
van der Zee, AGJ
Citation: Mjw. Berends et al., The importance of family history in young patients with endometrial cancer, EUR J OB GY, 82(2), 1999, pp. 139-141
Authors:
Bakker, M
Van der Graaf, WTA
Piers, DA
Franssen, EJF
Groen, HJM
Smit, EF
Kool, W
Hollema, H
Muller, EA
de Vries, EGE
Citation: M. Bakker et al., Tc-99m-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours, ANTICANC R, 19(3B), 1999, pp. 2349-2353
Authors:
Mourits, MJE
Van der Zee, AGJ
Willemse, PHB
Ten Hoor, KA
Hollema, H
De Vries, EGE
Citation: Mje. Mourits et al., Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen, GYNECOL ONC, 73(1), 1999, pp. 21-26